Spots Global Cancer Trial Database for stage iiia anal cancer
Every month we try and update this database with for stage iiia anal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | NCT00324415 | Anal Cancer | cetuximab cisplatin fluorouracil radiation thera... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | NCT00955240 | Anal Cancer | cetuximab cisplatin fluorouracil laboratory biom... radiation thera... | 18 Years - 80 Years | UNICANCER | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | NCT00068744 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | NCT00324415 | Anal Cancer | cetuximab cisplatin fluorouracil radiation thera... | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | NCT00093379 | Anal Cancer | Capecitabine Oxaliplatin Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | NCT00316888 | Anal Cancer | cetuximab cisplatin fluorouracil radiotherapy | 18 Years - | Eastern Cooperative Oncology Group | |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | NCT00423293 | Anal Cancer | fluorouracil mitomycin C Intensity-modul... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | NCT00068744 | Anal Cancer | cisplatin fluorouracil mitomycin C radiation thera... | 18 Years - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
